We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$12B
AUM Growth
+$538M
Cap. Flow
+$247M
Cap. Flow %
2.05%
Top 10 Hldgs %
58.6%
Holding
1,163
New
169
Increased
414
Reduced
393
Closed
182

Sector Composition

Rank Sector Weight
1 Energy 67.66%
2 Technology 4.68%
3 Healthcare 3.47%
4 Consumer Discretionary 3.35%
5 Financials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEEV icon
876
Veeva Systems
VEEV
$30.3B
$305K ﹤0.01%
1,499
-431
-22% -$86.8K
TOL icon
877
Toll Brothers
TOL
$14B
$304K ﹤0.01%
4,116
-1,419
-26% -$112K
SKE
878
Skeena Resources
SKE
$3.36B
$304K ﹤0.01%
66,564
CMA
879
DELISTED
Comerica
CMA
$303K ﹤0.01%
7,284
+1,882
+35% +$89.2K
AMPH icon
880
Amphastar Pharmaceuticals
AMPH
$825M
$302K ﹤0.01%
6,566
-2,325
-26% -$127K
BLD
881
DELISTED
TopBuild
BLD
$302K ﹤0.01%
1,199
-448
-27% -$123K
MHO icon
882
M/I Homes
MHO
$3.83B
$301K ﹤0.01%
3,582
-1,888
-35% -$175K
AUTL
883
Autolus Therapeutics
AUTL
$386M
$299K ﹤0.01%
128,147
+927
+0.7% +$2.64K
BLDR icon
884
Builders FirstSource
BLDR
$7.84B
$296K ﹤0.01%
2,377
-1,512
-39% -$209K
AX icon
885
Axos Financial
AX
$5.45B
$296K ﹤0.01%
7,815
-620
-7% -$26.2K
SRRK icon
886
Scholar Rock
SRRK
$5.71B
$295K ﹤0.01%
41,535
+1,628
+4% +$10.9K
SBOW
887
DELISTED
SilverBow Resources, Inc.
SBOW
$294K ﹤0.01%
+8,230
New +$300K
VYGR icon
888
Voyager Therapeutics
VYGR
$187M
$294K ﹤0.01%
+37,900
New +$346K
MEDP icon
889
Medpace
MEDP
$16.8B
$293K ﹤0.01%
1,212
-599
-33% -$153K
MUX icon
890
McEwen Inc
MUX
$1.03B
$293K ﹤0.01%
45,049
LAC
891
DELISTED
Lithium Americas Corp. Common Shares
LAC
$292K ﹤0.01%
17,183
+6,004
+54% +$113K
OCFC icon
892
OceanFirst Financial
OCFC
$1.7B
$292K ﹤0.01%
20,178
+5,008
+33% +$84.3K
HRMY icon
893
Harmony Biosciences
HRMY
$2.04B
$291K ﹤0.01%
+8,870
New +$308K
ITOS
894
DELISTED
iTeos Therapeutics
ITOS
$289K ﹤0.01%
26,426
+137
+0.5% +$1.75K
ALDX icon
895
Aldeyra Therapeutics
ALDX
$91.7M
$289K ﹤0.01%
43,250
+192
+0.4% +$1.43K
MLYS icon
896
Mineralys Therapeutics
MLYS
$2.35B
$287K ﹤0.01%
30,148
+117
+0.4% +$1.53K
CLX icon
897
Clorox
CLX
$11.6B
$286K ﹤0.01%
2,182
+67
+3% +$10.2K
SGML icon
898
Sigma Lithium
SGML
$1.08B
$285K ﹤0.01%
8,778
+3,104
+55% +$111K
ASRT
899
DELISTED
Assertio
ASRT
$283K ﹤0.01%
7,373
+3,684
+100% +$215K
JBIO
900
Jade Biosciences
JBIO
$1.22B
$277K ﹤0.01%
583
+60
+11% +$32.5K

Similar funds

ALPS Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, ALPS Advisors held 1,163 positions worth $12B, up 4.7% from $11.5B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

ALPS Advisors's Q3 2023 filing shows 169 new, 414 increased, 393 reduced and 182 closed positions. Its largest new stake was Schwab Fundamental US Large Company Index ETF: 2,126,955 shares worth $39.7M. The largest sale was Magellan Midstream Partners, L.P., an estimated $827M.

By sector, the portfolio is most concentrated in Energy at 68% of assets, up from 64% a quarter earlier, followed by Technology and Healthcare.

  • ALPS Advisors's largest Q3 2023 buy was Schwab Fundamental US Large Company Index ETF: 2,126,955 shares worth $39.7M.
  • ALPS Advisors added most to Enterprise Products Partners in Q3 2023, an estimated $170M increase.
  • ALPS Advisors's biggest Q3 2023 reduction was S&P Global, cutting an estimated $22.8M.
  • ALPS Advisors fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $827M.
  • ALPS Advisors's ten largest holdings make up 59% of its $12B portfolio in Q3 2023.
  • ALPS Advisors opened 169 new positions and closed 182 in Q3 2023.
  • ALPS Advisors's portfolio value rose 4.7% quarter-over-quarter to $12B.

Based on ALPS Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.